Cart
sales@molnova.com
Fosifidancitinib
CAS No. 1237168-58-9
Fosifidancitinib( —— )
Catalog No. M28194 CAS No. 1237168-58-9
Fosifidancitinib is a potent inhibitor of JAK 1 and JAK 3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 302 | Get Quote |
|
| 10MG | 447 | Get Quote |
|
| 25MG | 714 | Get Quote |
|
| 50MG | 1017 | Get Quote |
|
| 100MG | 1368 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFosifidancitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionFosifidancitinib is a potent inhibitor of JAK 1 and JAK 3.
-
DescriptionFosifidancitinib is a potent inhibitor of JAK 1 and JAK 3.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetJAK
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1237168-58-9
-
Formula Weight505.39
-
Molecular FormulaC21H21FN5O7P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1cc(Nc2ncc(C)c(Nc(cc3)cc(N4COP(O)(O)=O)c3OC4=O)n2)cc(OC)c1F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kungl AJ, et al. Molecular dynamics simulation of the rare amino acid LL-dityrosine and a dityrosine-containing peptide: comparison with time-resolved fluorescence. Biochim Biophys Acta. 1994 Dec 15;1201(3):345-52.
molnova catalog
related products
-
JAK-IN-3
JAK-IN-3 is a potent JAK inhibitor that inhibits JAK3, JAK1, TYK2, and JAK2, and can be used for the study of immune system disorders.
-
Oclacitinib
Oclacitinib(PF03394197) is a potent and selective JAKs inhibitor with IC50 of 10-99 nM.
-
S-Ruxolitinib
Ruxolitinib (INCB018424) is the first potent selective JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM in cell-free assays.
